Celia Darland
The University of Texas at San Antonio Health Science Center · 7 works · 3,635 citations · h-index 5
Top works
- A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients
- Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis
- 55 METABOLIC AND ANTI-INFLAMMATORY BENEFICIAL EFFECTS OF PIOGLITAZONE (PIO) TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND THEIR ASSOCIATIONS WITH HISTOLOGICAL IMPROVEMENT
- BASIC NUTRITION AND DIET THERAPY. Corinne H. Robinson. 4th ed, Macmillan Publishing Co, New York, Collier Macmillan Publishers, London, 1980. 383 pp illustrated, paperback, $12.00